Pricing

Applied Therapeutics Inc (APLT)

followers ·
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Shoshana Shendelman
Employees:
30
545 5TH AVENUE, SUITE 1400, NEW YORK, NY, 10017
212-220-9319
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosmia in healthy volunteers and adults. The company also develops AT-001 that is in phase III clinical trials for treating diabetic cardiomyopathy, as well as for treatment of diabetic peripheral neuropathy.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available